Two High-Level FDA Vaccine Officials Stepping Down Soon: Spokeswoman

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Md., on Aug. 29, 2020. Andrew Kelly/Reuters

Two senior Food and Drug Administration (FDA) vaccine regulators are planning to leave the agency in the coming weeks, said the FDA on Tuesday.

The regulator is “confident in the expertise and ability of our staff to continue our critical public health work, including evaluating COVID-19 vaccines,” FDA spokeswoman Stephanie Caccomo said in a statement to news outlets in confirming the planned departures of Dr. Marion Gruber, the head of the FDA’s Office of Vaccines Research and Review (OVRR), and Gruber’s deputy, Dr. Philip Krause.